Projected Income Statement: Repligen Corporation

Forecast Balance Sheet: Repligen Corporation

Forecast Balance Sheet - Repligen Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -238 -339 -682 -232 -23.8 -811 -1,022 -1,293
Change - -42.44% -101.18% 65.98% 89.74% -3,306.42% -26.02% -26.52%
Announcement Date 2/17/22 2/22/23 2/21/24 2/20/25 2/24/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Repligen Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 67.09 84.83 36.22 25.68 23.52 27.06 34.88 38.96
Change - 26.45% -57.3% -29.11% -8.4% 15.06% 28.89% 11.7%
Free Cash Flow (FCF) 1 51.93 87.25 77.7 149.7 93.9 87.27 156.7 223.5
Change - 68.02% -10.95% 92.7% -37.28% -7.06% 79.6% 42.61%
Announcement Date 2/17/22 2/22/23 2/21/24 2/20/25 2/24/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Repligen Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 34.38% 30.8% 20.03% 18.48% 19.01% 20.92% 23.13% 25.67%
EBIT Margin (%) 32.09% 28.97% 14.76% 12.94% 13.79% 16.15% 18.67% 21.55%
EBT Margin (%) 22.9% 27.34% 10.04% -4.26% 8.45% 0.99% 13.11% 18.39%
Net margin (%) 19.13% 23.2% 6.51% -4.02% 6.62% -1.99% 8.18% 10.68%
FCF margin (%) 7.74% 10.89% 12.16% 23.6% 12.72% 10.28% 14.65% 17.99%
FCF / Net Income (%) 40.48% 46.92% 186.87% -586.8% 192.04% -517.93% 179.12% 168.44%

Profitability

        
ROA 8.23% 7.72% 3.68% 3.14% 3.35% 1.88% 5.05% 7.35%
ROE 10.69% 10.3% 5.07% 4.51% 4.75% 3.08% 6.49% 8.92%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 10.01% 10.58% 5.67% 4.05% 3.19% 3.19% 3.26% 3.14%
CAPEX / EBITDA (%) 29.1% 34.36% 28.31% 21.9% 16.76% 15.24% 14.09% 12.22%
CAPEX / FCF (%) 129.2% 97.23% 46.62% 17.15% 25.05% 31.01% 22.25% 17.43%

Items per share

        
Cash flow per share 1 3.862 4.096 2.174 2.046 2.076 1.534 3.253 4.236
Change - 6.05% -46.92% -5.86% 1.44% -26.09% 112.03% 30.2%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 30.56 34.39 35.35 35.17 37.39 50.33 49.68 53.38
Change - 12.53% 2.78% -0.5% 6.32% 34.61% -1.3% 7.45%
EPS 1 2.24 3.24 0.74 -0.46 0.86 -0.2875 1.413 2.108
Change - 44.64% -77.16% -162.16% 286.96% -133.43% 591.59% 49.15%
Nbr of stocks (in thousands) 55,289 55,524 55,832 56,027 56,291 56,693 56,693 56,693
Announcement Date 2/17/22 2/22/23 2/21/24 2/20/25 2/24/26 - - -
1USD
Estimates
2026 *2027 *
P/E -642x 131x
PBR 3.67x 3.72x
EV / Sales 11.4x 8.83x
Yield - -

EPS & Dividend

EPS & Dividend - Repligen Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Repligen Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Repligen Corporation
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Repligen Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
184.69USD
Average target price
202.22USD
Spread / Average Target
+9.49%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Repligen Corporation
  1. Stock Market
  2. Stocks
  3. RGEN Stock
  4. Financials Repligen Corporation